XML 13 R2.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2017
Dec. 31, 2016
Current assets:    
Cash and cash equivalents $ 104,295 $ 134,563
Restricted cash and restricted investments 23,254 34,416
Accounts receivable, net (amounts related to affiliates: 2017 - $6,155; 2016 - $8,258) 44,638 40,635
Prepaid expenses and other current assets (amounts related to affiliates: 2017 - $1,110; 2016 - $4,507) 11,667 11,011
Investments, at amortized cost 33,684 44,341
Total current assets 217,538 264,966
Restricted cash and restricted investments 8,661 6,000
Investments in and advances to affiliates 1,636 2,159
Property and equipment, net 35,459 31,179
Prepaid expenses and other non-current assets 9,782 10,043
Intangible assets, net 254,166 258,923
Goodwill 627,204 626,569
Total assets 1,154,446 1,199,839
Current liabilities:    
Accounts payable (amounts related to affiliates: 2017 - $8,593; 2016 - $13,480) 39,613 43,892
Accrued liabilities (amounts related to affiliates: 2017 - $2,107; 2016 - $3,211) 22,320 29,160
Accrued compensation and employee benefits 16,993 38,408
Deferred revenue 25,513 20,481
Total current liabilities 104,439 131,941
Long-term debt, net of discount 120,706 120,283
Other long-term liabilities 14,091 14,655
Deferred tax liabilities, net 18,470 20,846
Total liabilities 257,706 287,725
Commitments and Contingencies (See Note 9)
Shareholders' Equity (Deficit)    
Additional paid-in-capital 621,187 555,250
Retained earnings (accumulated deficit) 128,605 146,617
Total shareholders' equity (deficit) attributable to Evolent Health, Inc. 750,471 702,526
Non-controlling interests 146,269 209,588
Total shareholders' equity (deficit) 896,740 912,114
Total liabilities and shareholders' equity (deficit) 1,154,446 1,199,839
Class A    
Shareholders' Equity (Deficit)    
Common stock 570 506
Class B    
Shareholders' Equity (Deficit)    
Common stock $ 109 $ 153